Lv6
2749 积分 2021-01-15 加入
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
5天前
已完结
A renaissance in targeting the PI3K/AKT/mTOR pathway
5天前
已完结
TBAI-Mediated Cyclization and Methylsulfonylation of Propargylic Amides with Dimethyl Sulfite
8天前
已完结
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?
16天前
已完结
Vinylpyridine as a Tunable Covalent Warhead Targeting C797 in EGFR
16天前
已完结
Cathepsin B-Responsive Phosphatidylinositol 3-Kinase (PI3K) Prodrug for the Treatment of Pulmonary Fibrosis
16天前
已关闭
The role of hydrophilic linkers in next-generation antibody-drug conjugates
22天前
已完结
Discovery of 2-Methyl-2-(4-(2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1H-naphtho[1,2-d]imidazol-1-yl)phenyl)propanenitrile as a Novel PI3K/mTOR Inhibitor with Enhanced Antitumor Efficacy In Vitro and In Vivo
23天前
已完结
Design, synthesis, and pharmacological evaluation of triazine-based PI3K/mTOR inhibitors for the potential treatment of non-small cell lung cancer
23天前
已完结
Discovery of 2-Methyl-2-(4-(2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-6-yl)-1H-naphtho[1,2-d]imidazol-1-yl)phenyl)propanenitrile as a Novel PI3K/mTOR Inhibitor with Enhanced Antitumor Efficacy In Vitro and In Vivo
23天前
已完结
皖公网安备34019202002308
